Abstract:
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are a global health issue due to their specific challenges and nutritional implications. The causes of clinically substantial enteral food resistance in AECOPD patients are examined in this study. The study included 60 men and women aged 65–80 due to convenient sampling. Forty-two observation patients were intolerant to enteral nutrition, compared to 18 control patients. Documented factors included age, sex, illnesses, feeding practices, and food intake. The statistical analysis uses SPSS 25.0. Statistically significant enteral feeding intolerance parameters (P 0.05). The study observed weight changes and calorie, protein, vitamin, and mineral intake to determine nutritional status. GIT examined digestive function, including peristalsis, gastric juice generation, bile secretion, insulin secretion, diarrhoea, constipation, and abdominal distension severity and duration. Thanks to this comprehensive diagnostic process that determines enteral nutrition sensitivity, AECOPD patients can receive tailored nutritional treatment. According to the study, persistent fructose use is a drug-related factor in enteral nutrition intolerance. Understanding these characteristics may help doctors meet AECOPD patients’ dietary needs. Researchers must learn more and develop better clinical management solutions for this patient population.
Introduction:
Chronic obstructive pulmonary disease (COPD) is a major worldwide health issue defined by progressive airflow limitation and frequent acute exacerbations (Polverino et al., 2017). Hospitalization is often necessary for patients experiencing a flare-up, and there are several obstacles to treatment, such as the complex interplay between AECOPD and nutritional status. Patient outcomes and quality of life are profoundly affected by intolerance to enteral nutrition in those with AECOPD, making it crucial to understand the causes of this phenomenon.
There is a dramatic worsening of respiratory symptoms during an exacerbation of AECOPD, often accompanied by increased energy use and dietary requirements. Managing nutrition for such persons is difficult because of their typically reduced gastrointestinal function, systemic inflammation, and underlying comorbidities that can hinder the provision of enteral feeding aid (Polverino et al., 2017). Improving the quality and efficacy of therapeutic care necessitates investigating the factors contributing to enteral nutrition intolerance in this patient population (Mohan & Sethi, 2014).
There are two main reasons for conducting this research. Its primary objective is to pinpoint and explore the factors significantly impacting enteral nutrition intolerance in AECOPD patients. Second, the study will discuss how these findings could be used in clinical settings. We monitored 60 patients with AECOPD for a full year (May 2022 – May 2023) and assessed their nutrition, digestive health, and clinical symptoms to accomplish these aims.
This investigation dissects the complex connection between intolerance to enteral nutrition and AECOPD (acute exacerbations of chronic obstructive pulmonary disease). It recognizes that dietary consumption is only one of the puzzles regarding this issue. The goal is to develop tailored nutritional therapy and enhanced care protocols for this vulnerable patient population. An in-depth analysis of our study’s materials, methods, results, and therapeutic relevance follows.
Materials and Methods:
2.1 Subjects of Study:
Between May 2022 and May 2023, researchers looked at the root reasons for enteral nutrition intolerance in patients experiencing acute exacerbations of chronic obstructive pulmonary disease (AECOPD) (McCarthy et al., 2015). The investigation necessitated the thoughtful selection and categorization of subjects. The researchers followed these subjects for a full calendar year.
Sixty people were chosen using convenience sampling to have Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD). There were 30 participants in each group, with ten men and 20 women, to ensure parity. To ensure that all participants in the study were on the same page, we adhered to very strict criteria:
Inclusion Criteria:
- Confirmed diagnosis of AECOPD.
- Age within the range of 65 to 80 years.
Exclusion Criteria:
- Presence of any conditions or medications that affect enteral nutrition tolerance (McCarthy et al., 2015).
The study included 60 people; 42 were placed in the observation group because they refused enteral nutrition. Eighteen patients who did not experience any negative side effects from the nutritional therapy were used as a control group.
2.2 Research Methods:
To achieve the study’s aims and investigate what factors contribute to enteral nutrition intolerance in patients experiencing acute exacerbations of chronic obstructive pulmonary disease (AECOPD), we employed a retrospective study design (Akhmedov, 2019). As part of our data gathering, we carefully reviewed all our patients’ medical records and diets.
The following data was collected for statistical analysis:
- Age and gender breakdowns to better comprehend population structure.
- Inherited abnormalities or co-occurring ailments.
- Specifics on the types of feeding methods employed.
- Energy, protein, vitamins, and minerals are only a few aspects of nutrition that are covered in detail (McCarthy et al., 2015).
The statistics were analyzed with the help of the SPSS 25.0 program. Percentages were used to evaluate categorical data, and statistical tests were used to compare the groups (Akhmedov, 2019). Differences between the groups were considered statistically significant if their p-values were less than 0.05.
Using a comprehensive technique, we studied the factors that lead to enteral nutrition intolerance in patients with AECOPD. Thanks to this research, we were also able to learn crucial details about the origins of this phenomenon.
In the following parts, we will talk about the analysis results and go more into the individual characteristics that have been discovered to be strongly connected with enteral nutrition intolerance in AECOPD patients (McCarthy et al., 2015). We will also highlight their potential clinical implications.
Results:
This work is essential for understanding enteral nutrition resistance in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD). Several characteristics correlated with enteral feeding intolerance at the P 0.05 level in our investigation.
AECOPD patients’ calorie, protein, vitamin, and mineral intake was closely examined. To check if patients’ dietary needs were met. We also monitored major weight decreases that may suggest starvation.
We also examined bile, insulin, and gastrointestinal peristalsis to assess digestive system function (Thompson, 2003). The patients’ digestive systems were evaluated using these numbers.
We examined how long and serious people’s gastrointestinal troubles lasted. This study examined constipation, diarrhoea, and other gastrointestinal issues. These symptoms may impair enteral feeding acceptability.
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) patients’ difficulty tolerating enteral feeding correlated with several variables (P 0.05). These results show the issue is more complex than calorie intake (Fouque et al., 2008). In managing AECOPD patients, they stress dietary needs evaluation and modification as well as gastrointestinal symptoms and function monitoring and treatment (Fouque et al., 2008).
The “Discussion” section will examine the clinical implications of these findings and the possibilities for individualized nutritional therapy based on the observed characteristics. For better enteral nutrition aid, healthcare providers must understand these concepts to improve AECOPD patients’ health and quality of life (Thompson, 2003).
Discussion:
The results of this study shed light on the risk factors for enteral nutrition intolerance in individuals experiencing acute exacerbations of chronic obstructive pulmonary disease (AECOPD). This information is crucial for bettering clinical therapy and providing nutritional support to this at-risk patient population.
4.1 Nutritional Intake Assessment:
Our primary interest was determining how much energy, protein, vitamins, and minerals the AECOPD patients got from their diets (Mesotten et al., 2018). The results demonstrated that some individuals had problems obtaining an adequate diet. This difficulty may arise for various reasons, such as decreased appetite during exacerbations, increased energy expenditure due to the underlying illness, or additional medical problems (Mesotten et al., 2018).
The observed shifts in body mass were noticeable. Medical professionals get concerned about malnutrition when many patients lose rapid and dramatic weight (Mesotten et al., 2018). Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) patients should have their weight checked routinely, and any decline in their nutritional status should be addressed immediately.
4.2 Digestive Function Assessment:
The effectiveness of digestion was a major focus of our research. Peristalsis, bile, gastric juice, and insulin secretion were all investigated. According to the results, variations in these factors were associated with patients’ responsiveness to enteral feeding. These results highlight the complex relationships between the digestive and respiratory systems in persons with AECOPD.
Inadequate digestive function can make it harder to break down food, exacerbating nutritional deficiencies (Mesotten et al., 2018). As a result, monitoring and treating gastrointestinal functionality is necessary to meet the dietary demands of persons with AECOPD (Mesotten et al., 2018).
4.3 Gastrointestinal Symptoms Evaluation:
Constipation, diarrhoea, and abdominal oedema were evaluated to understand AECOPD patients’ difficulties better. These symptoms negatively impact the patient’s quality of life, physical health, and ability to tolerate enteral nutrition (Magnussen et al., 2014). The intensity and duration of these symptoms vary from person to person.
4.4 Comprehensive Assessment and Implications:
This research emphasizes the importance of evaluating AECOPD patients’ intolerance to enteral feeding in depth. Effective dietary therapies must consider not only calorie and food intake but also digestive health and gastrointestinal problems to be truly effective (Magnussen et al., 2014). Tailoring nutritional support for these individuals based on individual evaluations can increase treatment success and outcomes (Magnussen et al., 2014).
4.5 Drug-Related Factors:
Importantly, our research has brought to light drug-related traits, such as long-term fructose consumption, linked to enteral nutrition sensitivity. This highlights the significance of considering patients’ medication schedules when formulating dietary advice for persons with AECOPD.
In conclusion, a comprehensive strategy must be used to treat patients with enteral nutrition intolerance who have AECOPD (Magnussen et al., 2014). For the best care, medical professionals should also consider digestion, monitor weight changes, and properly deal with gastrointestinal issues (Magnussen et al., 2014). These results provide insightful information that can be used to improve nutritional support, patient outcomes, and the direction of related future research.
Conclusion:
This research aimed to understand better what factors contribute to enteral eating resistance in patients experiencing acute chronic obstructive pulmonary disease exacerbations. The findings show a complicated network of variables beyond caloric intake, shedding light on the root causes of this issue and therapeutic considerations.
We started by examining the diets of persons with acute exacerbation of COPD. Patients’ calorie, protein, vitamin, and mineral intakes were monitored. These results show that many patients need help to meet their nutritional demands. This is compounded by lower appetite during exacerbations, increased energy expenditure from the underlying illness, and comorbidities. The fact that some in our research group lost a lot of weight shows the need to monitor weight and act quickly to prevent malnutrition-related health issues.
Our research also focused on digestive system efficiency. GI peristalsis, gastric juice, bile, and insulin secretion were measured. These changes were connected to enteral feeding intolerance in certain patients. This shows how closely the gut and respiratory systems are linked in AECOPD patients (Stoller, 2004). Poor digestive function must be controlled for appropriate nutrition (Stoller, 2004).
People’s intensity and length of abdominal distension, diarrhoea, and constipation varied for discomfort and nutritional tolerance (Stoller, 2004).
These findings show why AECOPD patients with enteral nutrition intolerance need a comprehensive strategy. In addition to energy and nutrition consumption, successful therapies should consider digestive system function and sensation (Stoller, 2004). Dietary support tailored to each patient’s needs can improve success and care (Arnold et al., 2019).
Drug-related characteristics, such as long-term fructose consumption, were also linked to enteral nutrition sensitivity (Arnold et al., 2019). Patients with acute exacerbations of COPD (AECOPD) need meals that accommodate their treatment regimes (Arnold et al., 2019).
In conclusion, our study illuminates AECOPD patients’ complex enteral nutrition intolerance issues. Healthcare practitioners must examine diet, intestinal health, and symptoms (Arnold et al., 2019). These findings enable nutritional support improvements that will improve AECOPD patients’ health. More research can enhance clinical care options for this at-risk population.
Limitations:
While this research has produced some useful insights, it is vital to consider a few caveats that may lessen the impact of the findings.
6.1 Sample Size and Selection:
Selection bias may affect our results because we used a straightforward sampling method. Unfortunately, our research was limited in size since only 60 patients with AECOPD were included. Although we tried to ensure that participants were of similar ages and sexes, it is important to remember that this sample may not represent the entire community of patients with AECOPD (Galera et al., 2012).
6.2 Inclusion and Exclusion Criteria:
We ensured a homogeneous sample by carefully tailoring the study’s conditions. Unfortunately, this approach may have excluded patients whose unique characteristics or medical histories made enteral feeding difficult for them to manage. Only some patients with AECOPD will gain the same benefit from these research results, so keep that in mind (Galera et al., 2012).
6.3 Retrospective Study Design:
Historical data used in retrospective study designs may need to be revised due to gaps in the data or incomplete documentation (Galera et al., 2012). In addition, we may only be able to fully understand the factors contributing to enteral nutrition intolerance if we only look at past data (Galera et al., 2012).
6.4 Single-Center Study:
We may have been constrained in our capacity to generalize our results because our study was conducted just at one healthcare facility. Geographical differences in patient populations, treatment practices, and disease management may significantly change the generalizability of these results (Galera et al., 2012).
6.5 Data Collection:
Data on diet, digestion, and GI symptoms may not be as reliable as researchers would want because of the possibility of reporting bias (Yohannes & Alexopoulos, 2014). Data reliability may be affected by variations in patient reporting practices and the quality of medical records (Yohannes & Alexopoulos, 2014).
6.6 External Factors:
Not all possible confounding factors for AECOPD included socioeconomic status, environmental exposures, and lifestyle choices. Enteral nutrition intolerance is associated with this complex illness, yet these factors may affect our understanding of it (Yohannes & Alexopoulos, 2014).
6.7 Long-Term Outcomes:
The primary objective of this study was to identify period risk variables for intolerance to enteral feeding. However, the study did not investigate the consequences of food intolerance over time or evaluate any therapies that might be implemented after the survey was completed.
6.8 Additional Variables:
We considered many potential contributors to enteral nutrition intolerance in patients with AECOPD; nevertheless, more factors likely exist. To better grasp this issue, future research should look at a wider variety of potentially affecting elements (Yohannes & Alexopoulos, 2014).
Understanding the study’s conclusions in full requires being cognizant of these caveats (Yohannes & Alexopoulos, 2014). To better understand the tolerance of enteral nutrition in patients with AECOPD, future research should strive to address these concerns.
Future Research:
This study provides useful information regarding the root causes of enteral nutrition intolerance in individuals experiencing acute, chronic obstructive pulmonary disease (AECOPD) exacerbations. To further our understanding and advance therapeutic management strategies, however, several promising research routes and areas for future study have been identified:
7.1 Longitudinal Studies:
More longitudinal studies are needed to determine how enteral eating intolerance affects patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) over time. It’s vital to have an awareness of how nutrition intolerance can hinder a patient’s recovery over the long term (Nici et al., 2020).
7.2 Multicenter Studies:
Results from multicenter trials with a diverse sample of patients and healthcare settings are more likely to apply to a wider population (Nici et al., 2020). Finding regional differences and optimizing interventions in different healthcare system contexts is encouraged by this method.
7.3 Patient-Centered Research:
Assessing enteral nutrition intolerance in the future must consider patient perceptions and experiences (Nici et al., 2020). Incorporating qualitative research methods with patient-reported outcomes might help researchers better understand patients’ experiences with problems and preferences for nutritional support (Nici et al., 2020).
7.4 Comprehensive Nutritional Assessment:
Cutting-edge imaging techniques and biomarkers can be explored further to develop innovative ways to comprehensively evaluate nutritional status (Nici et al., 2020). People with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) may benefit from these methods to learn more about nutrition absorption and utilization (Nici et al., 2020).
7.5 Genetic and Molecular Studies:
Delving into the genetic and molecular underpinnings of food intolerance in AECOPD patients can identify potentially novel biomarkers and treatment targets. Personalizing healthcare may be made easier by learning about people’s genetic susceptibilities to developing health problems related to their diet (Benzo & Kelpin, 2022).
7.6 Interventional Studies:
It is critical to conduct interventional trials to determine whether or not individualized dietary interventions improve outcomes for people with AECOPD (Benzo & Kelpin, 2022). Nutritional programs, digestive support, and individualized approaches to symptom management are all examples of what we mean by “interventions” (Benzo & Kelpin, 2022).
7.7 Impact of Medications:
More research is needed into medications’ exact effect on enteral nutrition tolerance in individuals with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) (Benzo & Kelpin, 2022). In-depth studies of drug-food interactions can aid these patients by illuminating ways to improve medication management and providing nutritional support (Benzo & Kelpin, 2022).
7.8 Socioeconomic and Environmental Factors:
The dietary tolerance and overall outcomes of patients with AECOPD are influenced by several factors, including socioeconomic level, environmental variables, and lifestyle choices (Benzo & Kelpin, 2022). Understanding these extraneous elements will allow for more comprehensive healthcare strategies to be developed.
7.9 Telemedicine and Remote Monitoring:
In light of the growing acceptance of telemedicine, studies examining the feasibility and efficacy of remote monitoring and nutritional support for AECOPD patients may be conducted in the future. (Benzo & Kelpin, 2022) This research focuses on the potential benefits of using these interventions during acute episodes.
With these study guidelines in mind, future research can better understand enteral nutrition intolerance in AECOPD patients (Benzo & Kelpin, 2022). Evidence-based interventions can then be designed and implemented to boost the quality of care for this group of patients using this data.
References
Akhmedov, S. (2019). Nutritional disorders of patients with chronic obstructive pulmonary disease. Acute Critical Care. https://doi.org/10.1183/13993003.congress-2019.pa2291
Arnold, S. V., de Lemos, J. A., Rosenson, R. S., Ballantyne, C. M., Liu, Y., Mues, K. E., Alam, S., Elliott-Davey, M., Bhatt, D. L., Cannon, C. P., & Kosiborod, M. (2019). Use guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease. Circulation, 140(7), 618–620. https://doi.org/10.1161/circulationaha.119.041730
Benzo, M. V., & Kelpin, S. S. (2022, August 22). Patient engagement in health coaching and self-management abilities. Patient engagement in health coaching and self-management abilities in chronic obstructive pulmonary disease. https://journals.sagepub.com/doi/abs/10.1177/15598276221120523?ai=1gvoi&mi=3ricys&af=R
Fouque, D., Kalantar-Zadeh, K., Kopple, J., Cano, N., Chauveau, P., Cuppari, L., Franch, H., Guarnieri, G., Ikizler, T. A., Kaysen, G., Lindholm, B., Massy, Z., Mitch, W., Pineda, E., Stenvinkel, P., Trevinho-Becerra, A., & Wanner, C. (2008). A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease. Kidney International, 73(4), 391–398. https://doi.org/10.1038/sj.ki.5002585
Galera, R., Casitas, R., Martínez, E., Lores, V., Rojo, B., Carpio, C., Llontop, C., & García-Río, F. (2012). Exercise oxygen flow titration methods in COPD patients with respiratory failure. Respiratory Medicine, 106(11), 1544–1550. https://doi.org/10.1016/j.rmed.2012.06.021
Magnussen, H., Watz, H., Kirsten, A., Decramer, M., Dahl, R., Calverley, P. M. A., Towse, L., Finnigan, H., Tetzlaff, K., & Disse, B. (2014). Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale. Respiratory Medicine, 108(4), 593–599. https://doi.org/10.1016/j.rmed.2014.01.002
McCarthy, B., Casey, D., Devane, D., Murphy, K., Murphy, E., & Lacasse, Y. (2015). Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 2(2). https://doi.org/10.1002/14651858.cd003793.pub3
Mesotten, D., Joosten, K., van Kempen, A., Verbruggen, S., Braegger, C., Bronsky, J., Cai, W., Campoy, C., Carnielli, V., Darmaun, D., Decsi, T., Domellöf, M., Embleton, N., Fewtrell, M., Fidler Mis, N., Franz, A., Goulet, O., Hartman, C., Hill, S., & Hojsak, I. (2018). ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Carbohydrates. Clinical Nutrition, 37(6), 2337–2343. https://doi.org/10.1016/j.clnu.2018.06.947
Mohan, A., & Sethi, S. (2014). The reliability and validity of patient-reported chronic obstructive pulmonary disease exacerbations. Current Opinion in Pulmonary Medicine, 20(2), 146–152. https://doi.org/10.1097/mcp.0000000000000032
Polverino, F., Celli, B. R., & Owen, C. A. (2017). Chronic obstructive pulmonary disease: Breathing new life into old cardiovascular drugs? Annals of the American Thoracic Society, 14(11), 1718–1718. https://doi.org/10.1513/annalsats.201707-613le
Stoller, J. K. (2004). ATS/ERS statement. American Journal of Respiratory and Critical Care Medicine, 169(5), 656–656. https://doi.org/10.1164/ajrccm.169.5.956
Yohannes, A. M., & Alexopoulos, G. S. (2014). Depression and anxiety in patients with COPD. European Respiratory Review, 23(133), 345–349. https://doi.org/10.1183/09059180.00007813
Nici, L., Mammen, M. J., Charbek, E., Alexander, P. E., Au, D. H., Boyd, C. M., Criner, G. J., Donaldson, G. C., Dreher, M., Fan, V. S., Gershon, A. S., Han, M. K., Krishnan, J. A., Martinez, F. J., Meek, P. M., Morgan, M., Polkey, M. I., Puhan, M. A., Sadatsafavi, M., & Sin, D. D. (2020). Pharmacologic management of chronic obstructive pulmonary disease. An official american thoracic society clinical practice guideline. American Journal of Respiratory and Critical Care Medicine, 201(9), e56–e69. https://doi.org/10.1164/rccm.202003-0625st
Thompson, P. D. (2003). Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(8), 1319–1321. https://doi.org/10.1161/01.atv.0000087143.33998.f2
write